Medical device firm MC3 Cardiopulmonary has completed the acquisition of surgical cannula product assets from Terumo Cardiovascular, for an undisclosed sum.
As part of the deal, MC3 has acquired Terumo’s surgical cannula line, which includes brands such as Sarns Soft-Flow arterial cannula.
The Terumo surgical cannula line, which is claimed to be one of the largest cardiac surgery cannula lines across the globe, includes around 200 product SKUs.
The Soft-Flow arterial cannula is the world’s first dispersion tip aortic cannula designed for clinical users, said the company.
MC3 has developed modern 60,000ft² manufacturing facility on its 10 acre campus in Dexter, Michigan, to support the production of Soft-Flow arterial cannula, which is expected during the first half of 2016.
MC3 Cardiopulmonary CEO Scott Merz said: "This is a significant milestone for us, and we are excited to return the legacy of Soft-Flow arterial cannula to the users and patients it will serve.
"In order to support our goals as a global medical device company we have built a world-class facility just outside of Ann Arbor in Dexter, Michigan.
"The location provides close proximity to the University of Michigan, Detroit International Airport and skilled knowhow within our sector."
Established in 1991, as a spinout of the University of Michigan, MC3 is involved in developing medical devices to meet acute and chronic cardiopulmonary clinical needs.
Image: MC3’s new manufacturing facility at Dexter to support production of Soft-Flow arterial cannula. Photo: courtesy of MC3 Cardiopulmonary.